These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 26270441)

  • 1. Prognostic Value of Ki-67 Labeling Index and Postoperative Radiotherapy in WHO Grade II Meningioma.
    Choi Y; Lim DH; Yu JI; Jo K; Nam DH; Seol HJ; Lee JI; Kong DS; Suh YL; Nam H
    Am J Clin Oncol; 2018 Jan; 41(1):18-23. PubMed ID: 26270441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of patterns of failure and appraisal of postoperative radiation field for grade II-III meningioma.
    Lee JJB; Lee J; Yoon HI; Kim SH; Cho J; Lee KS; Chang JH; Suh CO
    J Neurooncol; 2019 Sep; 144(2):333-341. PubMed ID: 31278690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
    Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
    Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
    Roser F; Samii M; Ostertag H; Bellinzona M
    Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. World Health Organization Grade II Meningioma: A 10-Year Retrospective Study for Recurrence and Prognostic Factor Assessment.
    Champeaux C; Dunn L
    World Neurosurg; 2016 May; 89():180-6. PubMed ID: 26850975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant radiotherapy for atypical meningiomas.
    Bagshaw HP; Burt LM; Jensen RL; Suneja G; Palmer CA; Couldwell WT; Shrieve DC
    J Neurosurg; 2017 Jun; 126(6):1822-1828. PubMed ID: 27611201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma.
    Bruna J; Brell M; Ferrer I; Gimenez-Bonafe P; Tortosa A
    Neuropathology; 2007 Apr; 27(2):114-20. PubMed ID: 17494511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA topoisomerase II-alpha and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases.
    Korshunov A; Shishkina L; Golanov A
    Arch Pathol Lab Med; 2002 Sep; 126(9):1079-86. PubMed ID: 12204057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas.
    Ohba S; Kobayashi M; Horiguchi T; Onozuka S; Yoshida K; Ohira T; Kawase T
    J Neurosurg; 2011 May; 114(5):1278-87. PubMed ID: 21166572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spot scanning-based proton therapy for intracranial meningioma: long-term results from the Paul Scherrer Institute.
    Weber DC; Schneider R; Goitein G; Koch T; Ares C; Geismar JH; Schertler A; Bolsi A; Hug EB
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):865-71. PubMed ID: 22138457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.
    Lubgan D; Rutzner S; Lambrecht U; Rössler K; Buchfelder M; Eyüpoglu I; Fietkau R; Semrau S
    J Neurooncol; 2017 Sep; 134(2):407-416. PubMed ID: 28667597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.
    Keric N; Kalasauskas D; Freyschlag CF; Gempt J; Misch M; Poplawski A; Lange N; Ayyad A; Thomé C; Vajkoczy P; Meyer B; Ringel F
    J Neurooncol; 2020 Jan; 146(2):347-355. PubMed ID: 31900826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ki-67 index as a predictive marker of meningioma recurrence following surgical resection.
    Mizrachi M; Hartley B; Saleem S; Hintz E; Ziemba Y; Li J; Goenka A; Schulder M
    J Clin Neurosci; 2024 Jun; 124():15-19. PubMed ID: 38631196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between malignant subtypes of meningioma and clinical outcome.
    Ko KW; Nam DH; Kong DS; Lee JI; Park K; Kim JH
    J Clin Neurosci; 2007 Aug; 14(8):747-53. PubMed ID: 17499508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival and failure patterns in atypical and anaplastic meningiomas: A single-center experience of surgery and postoperative radiotherapy.
    Kumar N; Kumar R; Khosla D; Salunke PS; Gupta SK; Radotra BD
    J Cancer Res Ther; 2015; 11(4):735-9. PubMed ID: 26881510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracranial meningeal hemangiopericytoma: 10 years experience of a tertiary care Institute.
    Kumar N; Kumar R; Kapoor R; Ghoshal S; Kumar P; Salunke PS; Radotra BD; Sharma SC
    Acta Neurochir (Wien); 2012 Sep; 154(9):1647-51. PubMed ID: 22790838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
    Graffeo CS; Leeper HE; Perry A; Uhm JH; Lachance DJ; Brown PD; Ma DJ; Van Gompel JJ; Giannini C; Johnson DR; Raghunathan A
    World Neurosurg; 2017 Jul; 103():655-663. PubMed ID: 28450233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery for convexity meningioma: Simpson Grade I resection as the goal: clinical article.
    Hasseleid BF; Meling TR; Rønning P; Scheie D; Helseth E
    J Neurosurg; 2012 Dec; 117(6):999-1006. PubMed ID: 23061394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early postoperative radiotherapy improves progression free survival in patients with grade 2 meningioma.
    Aboukais R; Baroncini M; Zairi F; Reyns N; Lejeune JP
    Acta Neurochir (Wien); 2013 Aug; 155(8):1385-90; discussion 1390. PubMed ID: 23728501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment.
    Hammouche S; Clark S; Wong AH; Eldridge P; Farah JO
    Acta Neurochir (Wien); 2014 Aug; 156(8):1475-81. PubMed ID: 24965072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.